Extending life at its most trying times

When you or a loved one are facing cancer, you want to be at the best place for the best possible outcome. We understand. We have been nationally-recognized for our outcomes, quality and staff. But, equally important is how we treat you. We form a team with you and create a battle plan specifically for your cancer and for you. 


You are a survivor from the first day of your cancer diagnosis.


Methodist Estabrook Cancer Center Outcomes

In 2016 Methodist Estabrook Cancer Center marked its 60th continuous year of accreditation. The center was named one of only 22 cancer programs in the nation, and the only program in the area to achieve the Outstanding Achievement Award from the Commission on Cancer (CoC), a program of the American College of Surgeons (ACoS). Learn more about our outcomes in the 2016 Annual Report

Methodist Jennie Edmundson Cancer Center Outcomes

As the only nationally-accredited cancer program in southwest Iowa, the Cancer Center at Methodist Jennie Edmundson Hospital served patients from 14 counties as well as patients from 3 other states. Learn more about the outcomes in the 2015 Annual Report.

Cancer Program Practice Profile Reports (CP3R)

Our programs participate in the national Cancer Program Practice Profile Reports (CP3R) which compares our adherence to the standard of cancer care therapies for major cancers. This program, administered by the American College of Surgeons, allows us to benchmark the treatment we provide against Center for Disease Control (CDC) national benchmarks. Through this, we are continuously monitoring and improving the care we provide to you, and you are able to verify that the treatments we suggest are those which are nationally-recommended.

CP3R currently reports 23 quality measures covering these 10 primary sites for cancer: breast, colon, rectum, lung, cervix, gastric, ovary, endometrium, bladder, and kidney. 

 View our CP3R reported outcomes, all of which are more favorable than the benchmarked outcomes from the CDC.